PHGUF
Price:
$0.96
Market Cap:
$630.39M
Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of acute hereditary angioedema. It also engages in the development of rhC1INH for the treatment of pre-eclampsia, acute kidney injury, and COVID-19; leniolisib, a phosphoinositide 3-kinase delta (PI3K delta) to treat patients with activated PI3K delta syndrome; and alpha-glucosidase therapy for the treatment of pompe and fabry diseases. The com...[Read more]
Industry
Biotechnology
IPO Date
2002-05-08
Stock Exchange
PNK
Ticker
PHGUF
According to Pharming Group N.V.’s latest financial reports and current stock price. The company's current Enterprise Value is 696.82M. This represents a change of -19.56% compared to the average of 866.30M of the last 4 quarters.
The mean historical Enterprise Value of Pharming Group N.V. over the last ten years is 685.15M. The current 696.82M Enterprise Value has changed 10.07% with respect to the historical average. Over the past ten years (40 quarters), PHGUF's Enterprise Value was at its highest in in the December 2019 quarter at 1.25B. The Enterprise Value was at its lowest in in the June 2016 quarter at 95.43M.
Average
685.15M
Median
720.01M
Minimum
125.74M
Maximum
1.30B
Discovering the peaks and valleys of Pharming Group N.V. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 772.43%
Maximum Annual Enterprise Value = 1.30B
Minimum Annual Increase = -37.72%
Minimum Annual Enterprise Value = 125.74M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.04B | 5.98% |
2022 | 984.54M | 51.68% |
2021 | 649.11M | -37.72% |
2020 | 1.04B | -20.04% |
2019 | 1.30B | 113.57% |
2018 | 610.36M | -22.83% |
2017 | 790.92M | 427.24% |
2016 | 150.01M | 19.31% |
2015 | 125.74M | -17.02% |
2014 | 151.53M | 772.43% |
The current Enterprise Value of Pharming Group N.V. (PHGUF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
892.36M
5-year avg
1.00B
10-year avg
685.15M
Pharming Group N.V.’s Enterprise Value is greater than Garibaldi Resources Corp. (9.59M), less than Domino's Pizza Group plc (1.74B), less than IGG Inc (2.55B), greater than PureTech Health plc (313.18M), less than Sino Biopharmaceutical Limited (56.95B),
Company | Enterprise Value | Market cap |
---|---|---|
9.59M | $8.25M | |
1.74B | $1.50B | |
2.55B | $563.54M | |
313.18M | $478.84M | |
56.95B | $7.54B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharming Group N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharming Group N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Pharming Group N.V.'s Enterprise Value?
What is the highest Enterprise Value for Pharming Group N.V. (PHGUF)?
What is the 3-year average Enterprise Value for Pharming Group N.V. (PHGUF)?
What is the 5-year average Enterprise Value for Pharming Group N.V. (PHGUF)?
How does the current Enterprise Value for Pharming Group N.V. (PHGUF) compare to its historical average?